Bellberry is quite efficient as they are a private outfit, not one of the "public" ethics committees found at universities and public hospitals. One of the huge advantages of targeting all solid tumours is there are many private sites that can participate in the trial, unlike AML where all the patients are basically treated in the large public hospitals.
It is a great achievement of the entire Race team to reach this point and I am both proud and grateful for their enormous effort. We really are lucky to have such a great group of people working hard for us shareholders to make the dream of CPACS reality.
-
- There are more pages in this discussion • 776 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.015(1.25%) |
Mkt cap ! $205.8M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.17 | $79.54K | 67.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19660 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 9769 | 5 |
View Market Depth
| Last trade - 15.56pm 28/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |